周梦娇

团队介绍

周梦娇，女，讲师，博士研究生，专任教师，1990年7月生，汉族

研究方向：

纳米药物递送，肿瘤联合治疗。

近五年主持的科研项目：

1、江苏省科学技术厅，青年基金项目，BK20200977，基于维生素B2的智能响应型纳米药物用于联合治疗的研究，2020-07至2023-06，20万元，结题，主持；

2、南通市科学技术局，民生科技-面上项目，MS12018098，pH/氧化还原双重响应性的无载体纳米抗癌药物用于肿瘤靶向传递及协同治疗，2018-07至2020-06，10万元，结题，主持。

代表性论著：

1.       Mengjiao Zhou, Minjian Yuan, Yilan Jin, Qianqian Zhou, Yuting Yu, Jianan Li, Xing Dai, Xiaohua Zheng, Haijun Yu*, Weiqi Wang*, Vitamin B2-based ferroptosis promoter for sono-enhanced nanocatalytic therapy of triple-negative breast cancer.Adv. Funct. Mater.2023, 2303899. DOI:10.1002/adfm.202303899.

2.       Yongmei Zhao, Yuanlin Zheng, Yan Zhu, Kai Ding, Mengjiao Zhou*, Tianqing Liu*, Co-delivery of gemcitabine and Triapine by calcium carbonate nanoparticles against chemoresistant pancreatic cancer. Int. J. Pharmaceut.2023, 636, 122844.

3.       Yongmei Zhao, Tianqing Liu*, Mengjiao Zhou*, Immune-cell-derived exosomes for cancer therapy. Mol. Pharmaceutics2022, 19, 3042-3056.

4.       Mengjiao Zhou, MinjianYuan, Meng Zhang, Chenyi Lei, Omer Aras, Xiaohong Zhang*, Feifei An*, Combining histone deacetylase inhibitors (HDACis) with other therapies for cancer therapy. Eur. J. Med. Chem. 2021, 226, 113825.

5.       Jingqi Xin, Caiting Deng, Omer Aras, Mengjiao Zhou*, Chunsheng Wu*, Feifei An*, Chemodynamic nanomaterials for cancer theranostics. J. Nanobiotechnol.2021, 19, 192.

6.       Mengjiao Zhou, Shupeng Han, Omer Aras*, Feifei An*, Recent advances in paclitaxel-based self-delivery nanomedicine for cancer therapy. Curr. Med. Chem.2021, 28, 1-17.

7.       Mengjiao Zhou, Xiao Liu, Fangmin Chen, Lili Yang, Minjian Yuan, Ding-Yi Fu, Weiqi Wang*, Haijun Yu*, Stimuli-activatable nanomaterials for phototherapy of cancer. Biomed. Mater.2021, 16, 042008.

8.       Mengjiao Zhou, Yuqi Xie, Shujun Xu, Jingqi Xin, Jin Wang, Tao Han, Richard Ting, Jie Zhang*, Feifei An*, Hypoxia-activated nanomedicines for effective cancer therapy. Eur. J. Med. Chem.2020, 195, 112274.

9.       Mengjiao Zhou, Weijia Wei, Xianfeng Chen, Xiuzhen Xu, Xiaohong Zhang, Xiujuan Zhang*, pH and redox dual responsive carrier-free anticancer drug nanoparticles for targeted delivery and synergistic therapy. Nanomedicine: NBM.2019, 20, 102008.

10.   Mengjiao Zhou, Xiujuan Zhang*, Xiuzhen Xu, Xianfeng Chen*, Xiaohong Zhang*, Doxorubicin@Bcl-2 siRNA core@shell nanoparticles for synergistic anticancer chemotherapy. ACS Appl. Bio Mater.2018, 1, 289-297.

11.   Mengjiao Zhou, Xiujuan Zhang*, Caitong Yu, Xueyan Nan, Xianfeng Chen*, Xiaohong Zhang, Shape regulated anticancer activities and systematic toxicities of drug nanocrystals in vivo.Nanomedicine: NBM.2015, 12, 181-189.

12.   Caitong Yu#, MengjiaoZhou#, Xiujuan Zhang*, Weijia Wei, Xianfeng Chen*, Xiaohong Zhang*, Smart doxorubicin nanoparticles with high drug payload for enhanced chemotherapy against drug resistance and cancer diagnosis. Nanoscale2015, 13, 5683-5690.

13.   Mengjiao Zhou, Xiujuan Zhang*, Yinlong Yang, Zhuang Liu, Baishun Tian, Jiansheng Jie*, Xiaohong Zhang*, Carrier-free functionalized multidrug nanorods for synergistic cancer therapy. Biomaterials2013, 34, 8960-8967.